• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组干扰素与天然干扰素抗克里米亚-刚果出血热病毒的抗病毒活性比较。

Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.

作者信息

Karlberg Helen, Lindegren Gunnel, Mirazimi Ali

机构信息

KCB/Swedish Institute for Infectious Disease Control, SE-172 82 Solna, Sweden.

出版信息

Open Virol J. 2010 Apr 22;4:38-41. doi: 10.2174/1874357901004020038.

DOI:10.2174/1874357901004020038
PMID:20517491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2878986/
Abstract

As a first line of defence against a virus infection, mammalian cells elicit an innate immune response, characterized by secretion of type I interferons (IFN) and up-regulation of interferon stimulated genes (ISGs). We have previously included Crimean Congo Hemorrhagic Fever Virus (CCHFV) in the list of type I IFN-sensitive viruses. In this in vitro study, we have compared the antiviral activity of two recombinant IFN-alpha preparations (Roferon A and Intron A) with a natural IFN-alpha produced in human leukocytes (Multiferon). Our results clearly demonstrate that these commercially available IFNs have significant antiviral activities against CCHFV. However, we could show that Multiferon inhibits viral replication more efficiently than the two recombinant IFN alpha preparations.

摘要

作为抵御病毒感染的第一道防线,哺乳动物细胞会引发先天性免疫反应,其特征是分泌I型干扰素(IFN)并上调干扰素刺激基因(ISG)。我们之前已将克里米亚-刚果出血热病毒(CCHFV)列入I型IFN敏感病毒名单。在这项体外研究中,我们比较了两种重组IFN-α制剂(罗扰素A和干扰能)与人白细胞中产生的天然IFN-α(多抗干扰素)的抗病毒活性。我们的结果清楚地表明,这些市售IFN对CCHFV具有显著的抗病毒活性。然而,我们能够证明多抗干扰素比两种重组IFN-α制剂更有效地抑制病毒复制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee78/2878986/24017fcecda2/TOVJ-4-38_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee78/2878986/1a13e0072f90/TOVJ-4-38_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee78/2878986/24017fcecda2/TOVJ-4-38_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee78/2878986/1a13e0072f90/TOVJ-4-38_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee78/2878986/24017fcecda2/TOVJ-4-38_F2.jpg

相似文献

1
Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.重组干扰素与天然干扰素抗克里米亚-刚果出血热病毒的抗病毒活性比较。
Open Virol J. 2010 Apr 22;4:38-41. doi: 10.2174/1874357901004020038.
2
Antagonistic antiviral activity between IFN-lambda and IFN-alpha against lethal Crimean-Congo hemorrhagic fever virus in vitro.干扰素λ与干扰素α在体外对致死性克里米亚-刚果出血热病毒的拮抗抗病毒活性。
PLoS One. 2015 Feb 18;10(2):e0116816. doi: 10.1371/journal.pone.0116816. eCollection 2015.
3
Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.克里米亚-刚果出血热病毒会延迟先天免疫反应的激活。
J Med Virol. 2008 Aug;80(8):1397-404. doi: 10.1002/jmv.21222.
4
Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection.稳定占据克里米亚-刚果出血热病毒编码的去泛素化酶可阻断病毒感染。
mBio. 2019 Jul 23;10(4):e01065-19. doi: 10.1128/mBio.01065-19.
5
Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.评价细胞培养基和小鼠脑来源的克里米亚-刚果出血热病毒灭活疫苗在短暂免疫抑制(IS)小鼠模型中的效果。
PLoS Negl Trop Dis. 2020 Nov 23;14(11):e0008834. doi: 10.1371/journal.pntd.0008834. eCollection 2020 Nov.
6
RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.视黄酸诱导基因I(RIG-I)介导对克里米亚-刚果出血热病毒的抗病毒反应。
J Virol. 2015 Oct;89(20):10219-29. doi: 10.1128/JVI.01643-15. Epub 2015 Jul 29.
7
Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.用编码克里米亚-刚果出血热病毒衣壳蛋白和包膜蛋白的DNA质粒及/或病毒样颗粒进行免疫可诱导受攻击小鼠产生保护作用并使其存活。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02076-16. Print 2017 May 15.
8
Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.克里米亚-刚果出血热小鼠模型再现人类恢复期。
J Virol. 2019 Aug 28;93(18). doi: 10.1128/JVI.00554-19. Print 2019 Sep 15.
9
Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells.I型干扰素在人类靶细胞中抑制克里米亚-刚果出血热病毒。
J Med Virol. 2006 Feb;78(2):216-22. doi: 10.1002/jmv.20530.
10
Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.利用抗体介导的 I 型干扰素阻断在小鼠中探索克里米亚-刚果出血热病毒诱导的肝损伤。
J Virol. 2018 Oct 12;92(21). doi: 10.1128/JVI.01083-18. Print 2018 Nov 1.

引用本文的文献

1
Biochemical and in silico evaluation of recombinant E. coli aminopeptidase and in vitro processed human interferon α-2b.重组大肠杆菌氨肽酶与体外加工的人干扰素α-2b的生化及计算机模拟评估
Turk J Biol. 2018 Jun 13;42(3):240-249. doi: 10.3906/biy-1801-83. eCollection 2018.
2
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment.克里米亚-刚果出血热:流行病学趋势及治疗争议。
BMC Med. 2011 Dec 8;9:131. doi: 10.1186/1741-7015-9-131.

本文引用的文献

1
The interferon response circuit in antiviral host defense.抗病毒宿主防御中的干扰素反应通路。
Verh K Acad Geneeskd Belg. 2009;71(1-2):73-86.
2
DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244): Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever.辩论(见埃拉尔迪·N等人,口服利巴韦林治疗克里米亚-刚果出血热的疗效:来自土耳其的一项准实验研究。《感染杂志》2009年;58:238 - 244):口服利巴韦林治疗克里米亚-刚果出血热疗效评估中的偏倚和错误解读。
J Infect. 2009 Oct;59(4):284-6; author reply 286-9. doi: 10.1016/j.jinf.2009.08.006. Epub 2009 Aug 21.
3
Crimean-Congo hemorrhagic fever treated with ribavirin in a pregnant woman.利巴韦林治疗孕妇克里米亚-刚果出血热。
J Infect. 2009 Oct;59(4):281-3. doi: 10.1016/j.jinf.2009.08.004. Epub 2009 Aug 19.
4
The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising.利巴韦林在克里米亚-刚果出血热治疗中的作用:早期使用前景可期。
Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):929-33. doi: 10.1007/s10096-009-0728-2. Epub 2009 Mar 20.
5
Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.口服利巴韦林治疗克里米亚-刚果出血热的疗效:来自土耳其的一项准实验研究。
J Infect. 2009 Mar;58(3):238-44. doi: 10.1016/j.jinf.2009.01.014. Epub 2009 Feb 26.
6
Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets.经鼻内给予α干扰素可降低雪貂感染季节性甲型流感病毒的发病率。
J Virol. 2009 Apr;83(8):3843-51. doi: 10.1128/JVI.02453-08. Epub 2009 Feb 4.
7
Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.利巴韦林治疗对克里米亚-刚果出血热患者生存率的疗效评估:一项病例对照研究。
Jpn J Infect Dis. 2009 Jan;62(1):11-5.
8
Interferons: signaling, antiviral and viral evasion.干扰素:信号传导、抗病毒及病毒逃逸
Immunol Lett. 2009 Jan 29;122(1):1-11. doi: 10.1016/j.imlet.2008.11.002. Epub 2008 Dec 6.
9
Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis.针对克里米亚刚果出血热病毒的干扰素和细胞因子反应;一种新出现且被忽视的病毒性人畜共患病。
Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):395-404. doi: 10.1016/j.cytogfr.2008.11.001. Epub 2008 Nov 21.
10
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients.克里米亚-刚果出血热病毒患者的病毒检测及病毒载量监测
Emerg Infect Dis. 2007 Jul;13(7):1097-100. doi: 10.3201/eid1307.070068.